Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-09

DMAC vs MNPR: stock comparison and AI forecast

Diamedica Therapeutics Inc. (DMAC) and Monopar Therapeutics (MNPR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

DMAC Diamedica Therapeutics Inc.

Price
$9.36 +45.1% · 6M
Market Cap
$505M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

MNPR Monopar Therapeutics

Market Cap
$479M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

DMAC · MNPR

Key facts

  • DMAC and MNPR have similar market capitalizations ($505M and $479M).
  • DMAC carries 0.17 times debt per unit of equity, against 0.03 times for MNPR.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricDMACMNPR
Market Cap$505M$479M
P/B Ratio13.17x3.66x
Book Value/Share$0.71$19.50
Revenue/Share–$0.00
FCF/Share$-0.58–

Profitability & Margins

MetricDMACMNPR
ROE-97.9%-13.6%
ROA-83.4%-13.2%
ROIC-102.1%-16.9%
Tax Rate-0.1%–

Financial Health

MetricDMACMNPR
Current Ratio6.72x33.56x
D/E Ratio0.17x0.03x
Financial Leverage1.17x1.03x
Interest Coverage-2134.0x-24.4x
Working Capital$38M$131M

Cash Flow

MetricDMACMNPR
Operating Cash Flow-$32M-$12M
Free Cash Flow-$32M–
Capital Spending-$30K–

Operational Efficiency

MetricDMACMNPR
Asset Turnover–0.00x

Income Statement

MetricDMACMNPR
Total Revenue–$0.00M
Operating Income-$39M-$22M
Net Income-$38M-$18M
R&D Expense$29M$15M

Dividend & Shareholder Information

MetricDMACMNPR
Shares Outstanding54M7M
FAQ

DMAC vs MNPR: stock comparison and AI forecast

Which is bigger, DMAC or MNPR?

DMAC and MNPR have similar market capitalizations ($505M and $479M).

Which one does Intratio's AI model rank higher, DMAC or MNPR?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.